MIM
MLAB icon

MetLife Investment Management’s Mesa Laboratories MLAB Stock Holding History

MetLife Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$255K Hold
2,888
– – ﹤0.01% 2096
2025
Q4 		$227K Hold
2,888
– – ﹤0.01% 2210
2025
Q3 		$194K Hold
2,888
– – ﹤0.01% 2336
2025
Q2 		$272K Hold
2,888
– – ﹤0.01% 2015
2025
Q1 		$343K Sell
2,888
-68
-2% -$9.27K ﹤0.01% 1911
2024
Q4 		$390K Hold
2,956
– – ﹤0.01% 1932
2024
Q3 		$384K Hold
2,956
– – ﹤0.01% 1927
2024
Q2 		$256K Buy
2,956
+288
+11% +$30.2K ﹤0.01% 2092
2024
Q1 		$293K Hold
2,668
– – ﹤0.01% 1970
2023
Q4 		$280K Hold
2,668
– – ﹤0.01% 2047
2023
Q3 		$280K Hold
2,668
– – ﹤0.01% 1999
2023
Q2 		$343K Hold
2,668
– – ﹤0.01% 1938
2023
Q1 		$466K Hold
2,668
– – ﹤0.01% 1687
2022
Q4 		$443K Hold
2,668
– – ﹤0.01% 1714
2022
Q3 		$376K Hold
2,668
– – ﹤0.01% 1842
2022
Q2 		$544K Hold
2,668
– – ﹤0.01% 1590
2022
Q1 		$680K Buy
2,668
+938
+54% +$255K ﹤0.01% 1587
2021
Q4 		$568K Hold
1,730
– – ﹤0.01% 1444
2021
Q3 		$523K Buy
1,730
+170
+11% +$48.3K ﹤0.01% 1493
2021
Q2 		$423K Hold
1,560
– – ﹤0.01% 1671
2021
Q1 		$380K Sell
1,560
-460
-23% -$127K ﹤0.01% 1679
2020
Q4 		$579K Hold
2,020
– – 0.01% 1414
2020
Q3 		$515K Buy
2,020
+315
+18% +$74.8K 0.01% 1354
2020
Q2 		$370K Hold
1,705
– – ﹤0.01% 1540
2020
Q1 		$385K Hold
1,705
– – 0.01% 1349
2019
Q4 		$425K Hold
1,705
– – ﹤0.01% 1548
2019
Q3 		$405K Buy
1,705
+231
+16% +$53.4K ﹤0.01% 1535
2019
Q2 		$360K Hold
1,474
– – ﹤0.01% 1680
2019
Q1 		$340K Hold
1,474
– – ﹤0.01% 1682
2018
Q4 		$307K Hold
1,474
– – ﹤0.01% 1662
2018
Q3 		$274K Hold
1,474
– – ﹤0.01% 1911
2018
Q2 		$311K Hold
1,474
– – ﹤0.01% 1699
2018
Q1 		$219K Hold
1,474
– – ﹤0.01% 1836
2017
Q4 		$183K Buy
+1,474
New +$206K ﹤0.01% 1982

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

MetLife Investment Management's MLAB Position: Q1 2026 in Review

MetLife Investment Management held its Mesa Laboratories (MLAB) position steady in Q1 2026 at 2,888 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

MetLife Investment Management first reported a position in MLAB in Q4 2017 and has held it in 34 quarters since. The position peaked at $680K in Q1 2022. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • MetLife Investment Management held 2,888 shares of Mesa Laboratories worth $255K as of Q1 2026.
  • MetLife Investment Management left its Mesa Laboratories share count unchanged in Q1 2026.
  • Mesa Laboratories made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2096 holding.
  • MetLife Investment Management first reported a position in Mesa Laboratories in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Mesa Laboratories position peaked at $680K in Q1 2022.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.